Sep 25th, 2006, 16:57
|
只看该作者 #621 | |
|
Senior Member
  
注册日期: Dec 2005
帖子: 195
积分:6
精华:1
  |
引用:
Naked short 通常是指没借到股票（或根本就没去借）就去卖空。举个例子，IB 共有1000股CSCO 股票(是他的客户的），他的另一个客户要short 2000股CSCO, 原则上，IB只能让他的客户去short 1000股CSCO.如这个客户short 了2000股，那有1000股就是naked short.（当然IB可去别的机构去再借1000股，如借到了，那末那1000股就不是naked short ) |
|
|
|
|
Sep 26th, 2006, 00:16
|
只看该作者 #625 |
|
Senior Member
注册日期: Jun 2005
帖子: 2,045
积分:2
精华:2
声望: 281761
|
目前上市的和stem cell，cell clone相关的股票
Aastrom Biosciences ASTM Nasdaq Advanced Cell Technology ACTC Nasdaq OTC Anormed Inc. AOM TSX (Toronto) Bio-Matrix Scientific Group BMXG Pink Sheets BioMS Medical MS TSX (Toronto) Brainstorm Cell Therapeutics BCLI Nasdaq OTC CalbaTech CLBE Nasdaq OTC Chromos Molecular Systems CHR TSX (Toronto) Cord Blood America Inc. CBAI Nasdaq OTC Cryo-Cell International CCEL Nasdaq OTC Cryolife CRY NYSE Cytori Therapeutics CYTX Nasdaq EpiPharma EPHM Pink Sheets Geron GERN Nasdaq HepaLife Technologies HPLF Nasdaq OTC Lifecell Corp. LIFC Nasdaq Mesoblast MSB ASX (Australia) MicroIslet MII AMEX MultiCell Technologies MUCL Nasdaq OTC Ortec International ORTN Nasdaq OTC PharmaFrontiers PFTR Nasdaq OTC PharmaGap GAP TSX-Venture Pluristem PLRS Nasdaq OTC ReNeuron RENE AIM (London) StemCells STEM Nasdaq Stem Cell Therapeutics SSS TSX-Venture Thermogenesis KOOL Nasdaq TranXenoGen TXN AIM (London) Viacell VIAC Nasdaq Vitro Diagnostics VODG Nasdaq OTC Vitrolife VITR Stockholm Exchange |
|
|
|
|
Sep 26th, 2006, 00:20
|
只看该作者 #626 |
|
Senior Member
注册日期: Jun 2005
帖子: 2,045
积分:2
精华:2
声望: 281761
|
stem cell 背景资料
Investing in Stem Cell Research - Proceed with Caution For companies and investors interested in stem cell research, the Nov. 3 election yielded mixed results. The bad news was that Sen. John Kerry, who had promised to lift restrictions on stem cell research imposed by President George Bush, lost. The good news was that California passed a ballot initiative authorizing $3 billion over 10 years for stem cell research. It wasn’t an even split, however. Kerry’s defeat and the loss of any hope that he would lift federal sanctions hammered some of the leading companies in this controversial field. Stem Cells Controversial Human embryonic stem cell research is controversial because it destroys embryos and some feel that is the same as taking a human life. California, led by movie star turned governor Arnold Schwarzenegger, is betting that stem cell research and the biotechnology associated with it will be the growth industry of this decade. The promises, yet unrealized, of the benefits of stem cell research seem too good to be true. Human embryo stem cells have the ability grow into any cell in the body. Proponents believe that human embryonic stem cell research could lead to cures and treatment for diseases and conditions ranging from Alzheimer’s disease to paralysis. Stem Cell Research President Bush clamped restrictions on research in the area that has severely slowed the expansion of knowledge, according to industry and academic insiders. There are still companies involved in stem cell research. Some are involved in researching stem cells that come from sources other than embryos. These stem cells do not have the same universal capabilities as embryonic stem cells; however, they do hold some promise in specific applications. Human embryonic stem cell research remains controversial. It faces moral/ethic and legal obstacles that will not easily be overcome. What Should Investors do? How should investors approach this new industry? First, if you have moral/ethical objections to the use of human embryos in the research, you should not invest in this industry or any business that conflicts with your core values. If you abandon your core values for a quick buck, your values aren’t worth very much. Secondly, you should acknowledge this technology may be years from producing commercial products. This is not cutting edge, this is bleeding edge. Thirdly, picking winners now is very difficult. Everyone wants to pick the next Microsoft or Apple in its infancy, however if you look back at the tech boom, for every survivor there are 500 companies that don’t exist anymore. Conclusion Stem cell research may one day lead to “miracle” cures for a variety of diseases and conditions. We just don’t know when or if that day will come and which companies will lead the way. |
|
|
|
|
Oct 5th, 2006, 12:16
|
只看该作者 #629 | |
|
Senior Member
注册日期: Jul 2004
帖子: 203
声望: 112045
|
引用:
Have you ever heard of poisoned financing, death spiral, convertible debenture? MM often covers when companies issue more shares. If they sell short before the issued shares are handed to them, it is naked short. That is a reason why share prices are so low, even lower than 0.1 cent. |
|
I finally graduated.
|
||
|
|
|
